BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29187600)

  • 1.
    Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
    J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
    Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
    Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
    Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
    Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
    Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
    Harada Y; Izumi H; Noguchi H; Kuma A; Kawatsu Y; Kimura T; Kitada S; Uramoto H; Wang KY; Sasaguri Y; Hijioka H; Miyawaki A; Oya R; Nakayama T; Kohno K; Yamada S
    Tumour Biol; 2016 Jan; 37(1):1357-68. PubMed ID: 26296622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of polypeptide GalNAc-transferases in hematopoietic stem/progenitor cells.
    Cheng L; Wang X; Tan M; Zhou X; Wang Q
    Cell Biol Int; 2004; 28(8-9):635-40. PubMed ID: 15350598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.
    Ishikawa M; Kitayama J; Nariko H; Kohno K; Nagawa H
    J Surg Oncol; 2004 Apr; 86(1):28-33. PubMed ID: 15048677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of
    Kurita T; Thi TN; Koi C; Murakami M; Kagami S; Izumi H; Hachisuga T
    Anticancer Res; 2017 Jul; 37(7):3905-3910. PubMed ID: 28668893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.
    Inoue M; Takahashi S; Yamashina I; Kaibori M; Okumura T; Kamiyama Y; Vichier-Guerre S; Cantacuzène D; Nakada H
    Cancer Res; 2001 Feb; 61(3):950-6. PubMed ID: 11221889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation.
    Bagdonaite I; Pallesen EM; Ye Z; Vakhrushev SY; Marinova IN; Nielsen MI; Kramer SH; Pedersen SF; Joshi HJ; Bennett EP; Dabelsteen S; Wandall HH
    EMBO Rep; 2020 Jun; 21(6):e48885. PubMed ID: 32329196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.
    Bennett EP; Hassan H; Mandel U; Hollingsworth MA; Akisawa N; Ikematsu Y; Merkx G; van Kessel AG; Olofsson S; Clausen H
    J Biol Chem; 1999 Sep; 274(36):25362-70. PubMed ID: 10464263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess APP O-glycosylation by GalNAc-T6 decreases Aβ production.
    Akasaka-Manya K; Kawamura M; Tsumoto H; Saito Y; Tachida Y; Kitazume S; Hatsuta H; Miura Y; Hisanaga SI; Murayama S; Hashimoto Y; Manya H; Endo T
    J Biochem; 2017 Jan; 161(1):99-111. PubMed ID: 28053144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation.
    Rajpert-De Meyts E; Poll SN; Goukasian I; Jeanneau C; Herlihy AS; Bennett EP; Skakkebaek NE; Clausen H; Giwercman A; Mandel U
    Virchows Arch; 2007 Oct; 451(4):805-14. PubMed ID: 17694322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection.
    Li Z; Yamada S; Wu Y; Wang KY; Liu YP; Uramoto H; Kohno K; Sasaguri Y
    Oncotarget; 2016 Aug; 7(34):54463-54473. PubMed ID: 27276675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.
    Banford S; Timson DJ
    Curr Cancer Drug Targets; 2017; 17(1):53-61. PubMed ID: 27659430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 induces specific pp-GalNAc-T expression and alterations in mucin O-glycosylation in colonic epithelial cells.
    Kanoh A; Takeuchi H; Kato K; Waki M; Usami K; Irimura T
    Biochim Biophys Acta; 2008 Mar; 1780(3):577-84. PubMed ID: 17916404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
    Gu C; Oyama T; Osaki T; Li J; Takenoyama M; Izumi H; Sugio K; Kohno K; Yasumoto K
    Br J Cancer; 2004 Jan; 90(2):436-42. PubMed ID: 14735190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
    Li Z; Yamada S; Inenaga S; Imamura T; Wu Y; Wang KY; Shimajiri S; Nakano R; Izumi H; Kohno K; Sasaguri Y
    Br J Cancer; 2011 Jun; 104(12):1882-9. PubMed ID: 21587259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.